StonvexLoading…
StonvexStonvexStonvexCore line items from CLMT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.03B | $4.14B | $3.10B | $2.02B |
Operating Income | $-171.30M | $108.70M | $173.20M | $-149.70M |
Net Income | $-317.00M | $-33.80M | $3.50M | $-309.90M |
EPS (Diluted) | $-3.64 | $-0.39 | $0.04 | $-3.58 |
Total Assets | $2.75B | $2.69B | $2.73B | $2.78B |
Total Liabilities | $3.55B | $3.18B | $3.18B | $3.54B |
Cash & Equivalents | $138.60M | $125.10M | $94.60M | $110.60M |
Free Cash Flow OCF − CapEx | $-99.40M | $56.60M | $-47.20M | $-62.30M |
Shares Outstanding | 87.04M | 86.78M | 86.75M | 86.66M |